These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8689981)

  • 21. Pyrogen contamination of total parenteral nutrition solutions: a case report.
    Stansfield SA; Jones EL
    Can J Hosp Pharm; 1983; 36(1):21, 28. PubMed ID: 10310172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequences.
    Khuu HM; Cowley H; David-Ocampo V; Carter CS; Kasten-Sportes C; Wayne AS; Solomon SR; Bishop MR; Childs RM; Read EJ
    Cytotherapy; 2002; 4(6):539-49. PubMed ID: 12568990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Newspapers' coverage of contaminated intravenous fluids from an Indian manufacturer distributed by Public Central Medical Supplies in Sudan: lessons to be learned.
    Ali GK; Alfadl AA; Fathelrahman AI
    Health Policy; 2011 Jul; 101(2):172-7. PubMed ID: 21269723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survey on sterility testing practices.
    Akers JE; Carleton FJ; Clements WC; Woods JA
    J Parenter Sci Technol; 1987; 41(6):197-206. PubMed ID: 3437369
    [No Abstract]   [Full Text] [Related]  

  • 25. USP perspectives on particle contamination of injectable products.
    Gallelli JF; Groves MJ
    J Parenter Sci Technol; 1993; 47(6):289-92. PubMed ID: 8120733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fungal endophthalmitis after a single intravenous administration of presumably contaminated dextrose infusion fluid.
    Gupta A; Gupta V; Dogra MR; Chakrabarti A; Ray P; Ram J; Patnaik B
    Retina; 2000; 20(3):262-8. PubMed ID: 10872931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbial growth tests in anti-neoplastic injectable solutions.
    Paris I; Paci A; Rey JB; Bourget P
    J Oncol Pharm Pract; 2005 Mar; 11(1):7-12. PubMed ID: 16460598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact.
    Lowder JN; Whelton P
    Cytotherapy; 2003; 5(5):377-90. PubMed ID: 14578100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of a safer approach to intravenous drug infusions: failure mode effects analysis.
    Apkon M; Leonard J; Probst L; DeLizio L; Vitale R
    Qual Saf Health Care; 2004 Aug; 13(4):265-71. PubMed ID: 15289629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statistical bases for defining level of assurance.
    Schofield T
    Dev Biol (Basel); 2006; 123():209-16; discussion 217-22. PubMed ID: 16566447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ensuring the sterility of infusion solutions].
    Meyer KH; Bickel H
    Klin Anasthesiol Intensivther; 1977; (14):18-20. PubMed ID: 926685
    [No Abstract]   [Full Text] [Related]  

  • 32. [Results of the first 6 months' experience in the monitoring of the sterility of injectable solutions].
    Pappalardo G
    Rev Med Suisse Romande; 1986 Feb; 106(2):163-71. PubMed ID: 3515496
    [No Abstract]   [Full Text] [Related]  

  • 33. The quality of antimalarials available in Yemen.
    Abdo-Rabbo A; Bassili A; Atta H
    Malar J; 2005 Jun; 4():28. PubMed ID: 15987508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying human and livestock sources of fecal contamination in Kenya with host-specific Bacteroidales assays.
    Jenkins MW; Tiwari S; Lorente M; Gichaba CM; Wuertz S
    Water Res; 2009 Nov; 43(19):4956-66. PubMed ID: 19692107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some aspects of toxic contaminants in herbal medicines.
    Chan K
    Chemosphere; 2003 Sep; 52(9):1361-71. PubMed ID: 12867165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Technique for microbiological testing of in-use intravenous solutions and administration sets.
    Lim JC
    Am J Hosp Pharm; 1979 Sep; 36(9):1202-4. PubMed ID: 386787
    [No Abstract]   [Full Text] [Related]  

  • 37. A study of particulate matter in I.V. infusion fluids.
    Davis NM; Turco S; Sivelly E
    Am J Hosp Pharm; 1970 Oct; 27(10):822-6. PubMed ID: 5473472
    [No Abstract]   [Full Text] [Related]  

  • 38. Final in-line filtration: removal of contaminants from IV fluids and drugs.
    Rapp RP; Bivins BA
    Hosp Formul; 1983 Dec; 18(12):1124-8. PubMed ID: 10264358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vanadium-contaminated perioperatively administered infusion solutions and drugs.
    Heinemann G; Vogt W
    Biol Trace Elem Res; 2000; 75(1-3):227-34. PubMed ID: 11051612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Particulate matter in intravenous infusion fluids--phase 3.
    Turco SJ; Davis NM
    Am J Hosp Pharm; 1973 Jul; 30(7):611-3. PubMed ID: 4715106
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.